Recent Operating News Today

- Expecting total of 8 WiSA E licensing agreements by year-end 2024, up from 5 currently - - First WiSA E-enabled products expected to contribute revenue in 2H 2024 - ...

Initiated discussions with FDA regarding accelerated approval pathway for CNM-Au8® for the treatment of ALS with the objective of submitting an NDA in 2024Released long-term data from the open-label extension

Firstquarter revenue totaled$160.6 million, representing an increase of16%year-over-year.Trailing four quarter average Net Dollar Retention Rate was113%at the end of thefirstquarter of fiscal2025as compared to127%at the end offirstquarter of fiscal2024.Firstquarter GAAP

Second quarter revenue totaled $143.2 million, representing an increase of 26% year-over-year.Trailing four quarter average Net Dollar Retention Rate was 124% at the end of the second quarter of...

Second quarter revenue totaled $143.2 million, representing an increase of 26% year-over-year.Trailing four quarter average Net Dollar Retention Rate was...

IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure" or the "Company"), developer of the ProSense® System, a minimally-invasive cryoablation technology that destroys tumors by freezing as an alternative to surgical tumor removal, today reported financial results as of and for the six months ended June 30, 2023, as well as operational and recent corporate developments.

PARSIPPANY, N.J., Aug. 07, 2023 -- Lincoln Educational Services Corporation today announced financial and operating results for the second quarter as well as recent business developments. Second...

07.06.2023 - First quarter revenue totaled $138.0 million, representing an increase of 37% year-over-year.Trailing four quarter average Net Dollar Retention Rate was 127% at the end of the first quarter of fiscal 2024 and 133% at the end of first quarter of ...

Physician Interest and Adoption of ProSense in the U.S. Builds Momentum as ProSense is Featured at Medical Conferences and Educational Courses ProSense was the...

ALS biomarker and long-term clinical data expected mid-yearNeurology expert Ben Greenberg, M.D., M.H.S., joined as Head of Medical SALT LAKE CITY, May ...